Published in J Gen Microbiol on December 01, 1993
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2000) 4.82
Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiol Mol Biol Rev (1999) 2.13
Inorganic polyphosphate in Vibrio cholerae: genetic, biochemical, and physiologic features. J Bacteriol (2000) 1.50
Effect of cold starvation, acid stress, and nutrients on metabolic activity of Helicobacter pylori. Appl Environ Microbiol (2002) 1.32
Polyphosphate--an ancient energy source and active metabolic regulator. Microb Cell Fact (2011) 1.19
Direct labeling of polyphosphate at the ultrastructural level in Saccharomyces cerevisiae by using the affinity of the polyphosphate binding domain of Escherichia coli exopolyphosphatase. Appl Environ Microbiol (2005) 0.99
Importance of polyphosphate kinase 1 for Campylobacter jejuni viable-but-nonculturable cell formation, natural transformation, and antimicrobial resistance. Appl Environ Microbiol (2009) 0.93
Accumulation of polyphosphate in Lactobacillus spp. and its involvement in stress resistance. Appl Environ Microbiol (2013) 0.84
Chromosome replication and segregation govern the biogenesis and inheritance of inorganic polyphosphate granules. Mol Biol Cell (2013) 0.83
A novel mechanism for resistance to the antimetabolite N-phosphonoacetyl-L-aspartate by Helicobacter pylori. J Bacteriol (1998) 0.81
Single-cell elemental analysis of bacteria: quantitative analysis of polyphosphates in Mycobacterium tuberculosis. Front Cell Infect Microbiol (2012) 0.80
Hyperconcentrated Sweet Whey, a New Culture Medium That Enhances Propionibacterium freudenreichii Stress Tolerance. Appl Environ Microbiol (2016) 0.75
Elucidation of the Metabolic Network of Helicobacter pylori J99 and Malaysian Clinical Strains by Phenotype Microarray. Helicobacter (2016) 0.75
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect (1993) 2.61
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
Structured reporting of medical findings: evaluation of a system in gastroenterology. Methods Inf Med (1992) 2.30
Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther (2013) 2.13
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther (2014) 2.11
Characterization of yellow plaques found in the small bowel during double-balloon enteroscopy. Endoscopy (2007) 2.06
Diagnostic and therapeutic impact of double-balloon enteroscopy. Endoscopy (2006) 2.03
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Analysis of nerves in chronic pancreatitis. Gastroenterology (1988) 2.01
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
[Magnet resonance imaging in common injuries of the wrist]. Unfallchirurg (2014) 2.01
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol Suppl (1988) 1.77
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
A retrospective analysis of emergency double-balloon enteroscopy for small-bowel bleeding. Endoscopy (2009) 1.72
Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment Pharmacol Ther (2008) 1.70
The role of infection in acute pancreatitis. Gut (1999) 1.66
Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology (1993) 1.66
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter (1998) 1.61
A pathogen-induced wheat gene encodes a protein homologous to glutathione-S-transferases. Mol Plant Microbe Interact (1992) 1.60
Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract (2008) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol (2003) 1.52
Cloning and sequencing of cDNAs encoding a pathogen-induced putative peroxidase of wheat (Triticum aestivum L.). Plant Mol Biol (1991) 1.50
13C-urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice. Scand J Gastroenterol (1998) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Chitinase in bean leaves: induction by ethylene, purification, properties, and possible function. Planta (1983) 1.47
Interdigestive cycling in chronic pancreatitis: altered coordination among pancreatic secretion, motility, and hormones. Gastroenterology (1995) 1.47
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46
Biliary strictures are not the cause of pain in patients with chronic pancreatitis. Pancreas (2004) 1.44
Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol (1999) 1.43
Characterization of an Arabidopsis-Phytophthora pathosystem: resistance requires a functional PAD2 gene and is independent of salicylic acid, ethylene and jasmonic acid signalling. Plant J (2001) 1.41
[Endogenous prostaglandin synthesis and gastritis: lack of correlation with endoscopic findings, Helicobacter colonization and leukocytic infiltration of the mucosa]. Z Gastroenterol (1992) 1.41
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
[Order in the chaos of classifications of erosions of the gastric mucosa]. Leber Magen Darm (1993) 1.39
Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity. Zentralbl Bakteriol (1993) 1.38
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study. Ital J Gastroenterol Hepatol (1998) 1.38
[Polymorphism in Helicobacter pylori--a key function in recurrence of infection?]. Med Klin (Munich) (1992) 1.37
Increased incidence of gallstones and prior cholecystectomy in patients with large bowel cancer. Am J Gastroenterol (1992) 1.37
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology (1992) 1.31
Ultrastructural localisation of urease in outer membrane and periplasm of Campylobacter pylori. J Clin Pathol (1989) 1.29
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology (1999) 1.27
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol (1995) 1.27
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
Subcellular immunocytochemical analysis detects the highest concentrations of glutathione in mitochondria and not in plastids. J Exp Bot (2008) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Sequence of a wheat cDNA encoding a pathogen-induced thaumatin-like protein. Plant Mol Biol (1991) 1.25
Role of phospholipase A2 in human acute pancreatitis. Gastroenterology (1989) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
ERCP using single-balloon instead of double-balloon enteroscopy in patients with Roux-en-Y anastomosis. Endoscopy (2008) 1.18
Helicobacter pylori infection: a clinical overview. Dig Liver Dis (2008) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. Lancet (1999) 1.16
Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. Br J Cancer (2002) 1.16
The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol (1998) 1.16
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther (2004) 1.16
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther (2001) 1.14
PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas (1991) 1.14
The quality of gastroenterological reports based on free text dictation: an evaluation in endoscopy and ultrasonography. Endoscopy (1991) 1.14
Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Am J Gastroenterol (1994) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut (1997) 1.13
Changes in peptidergic innervation in chronic pancreatitis. Pancreas (1992) 1.12
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol (2007) 1.10
Duodenum-preserving pancreatic head resection: Long-term results. J Gastrointest Surg (2006) 1.10
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol (1998) 1.08
The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut (1998) 1.08
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut (2005) 1.08
Immunocytochemical determination of the subcellular distribution of ascorbate in plants. Planta (2010) 1.07
Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia (1981) 1.06
Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol (1996) 1.05
Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am J Gastroenterol (1993) 1.03
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci (1998) 1.02
Chromoendoscopy: from a research tool to clinical progress. Dig Dis (2002) 1.02